Repare Therapeutics Operating Income

Repare Therapeutics (RPTX) currently reports a operating income of $-78M as of September 2025. That compares with $-93M in the prior-year period — up 15.7% year over year. Use the charts on this page to explore Repare Therapeutics's operating income history and peer comparisons.

Repare Therapeutics's operating income increased from $-93M to $-78M — a 15.7% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Repare Therapeutics reported $-78M in operating income as of September 2025. That compares with $-93M in the prior-year period — up 15.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Repare Therapeutics, and consider following RPTX for alerts when major investors trade the stock.

Repare Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-78M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPTX with unrelated industries.